Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-ared-4_03-cv-01507/USCOURTS-ared-4_03-cv-01507-165/pdf.json

Nature of Suit Code: 365
Nature of Suit: Personal Injury - Product Liability
Cause of Action: 28:1332 Diversity-Product Liability

---

IN THE UNITED STATES DISTRICT COURT

FOR THE EASTERN DISTRICT OF ARKANSAS

WESTERN DIVISION

 : MDL DOCKET NO. 4:03-CV-1507-WRW

IN RE: :

PREMPRO PRODUCTS LIABILITY :

LITIGATION :

ORDER1

The parties’ joint motion (Doc. No. 2250) to establish a scheduling order to consider

evidence regarding a scientifically supported causal link between estrogen-only hormone therapy

and breast cancer. Accordingly, the schedule is as follows:2

June 2 Plaintiffs file motion, designate experts, and disclose expert reports.

June 2 - July 1 Parties depose Plaintiffs’ experts.

July 15 Defendants must file response to Plaintiffs’ motion.

July 22 Plaintiffs must file reply to Defendants’ response.

July 29 Defendants file sur-reply.

Some time during the week of August 9, 2010, I may have a joint hearing with Judge

Montgomery in Minneapolis, Minnesota. I will try to finalize the details with her next week. If

she and I are unable to coordinate a time and date, the hearing likely will be held later that month

in Little Rock, Arkansas.

IT SO ORDERED this 13th day of May, 2010.

 /s/ Wm. R. Wilson, Jr.____________

 UNITED STATES DISTRICT JUDGE

1

This Order also grants Doc. No. 12 in Davis, et al. v. Wyeth, Inc., et al., No. 4:07-CV00173. Any future pleadings on this subject should be filed in MDL 1507 only.

2

Each deadline is 5 p.m.

Case 4:03-cv-01507-BRW Document 2270 Filed 05/13/10 Page 1 of 1